Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes.
Ever since the original identification of fragments of KSHV DNA in Kaposi's sarcoma (KS) tissue by Chang et al. in 1994, PCR has been used successfully and extensively to detect the virus in clinical samples from the accepted etiological diseases of KS, PEL and MCD. However, a number of other clinical and epidemiological studies claiming evidence for KSHV in multiple myeloma or sarcoid and more recently in primary pulmonary hypertension, as well as claims about the biological significance of DNA sequence polymorphisms based just on small ORF26 PCR DNA fragments have not been convincing. Here, we evaluate the validity and interpretations of previous results in the context of both the observed rates and global patterns of sequence variability within an extended ORF26 locus, as well as from the perspective of the overall levels of KSHV variability found after sampling multiple loci across the complete KSHV genome. The results cast doubts on most claims for biological significance for these polymorphisms, which instead correlate with viral subtype clustering arising from geographic and ethnic divergence of the ancestral human hosts. In addition, we describe several observations that help to explain likely sources of the often either unexpectedly high or unexpectedly low levels of sporadic variability seen in the PCR DNA sequence data reported in some of those studies.
Zong
Jian-Chao
JC
Viral Oncology Program, Department of Oncology, Blunting Blaustein Cancer Research Building, Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21231-1000, United States.
Arav-Boger
Ravit
R
Alcendor
Donald J
DJ
Hayward
Gary S
GS
D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology / Q000821:virology; D014644:Genetic Variation; D016679:Genome, Viral; D005838:Genotype; D006566:Herpesviridae Infections / Q000453:epidemiology / Q000821:virology; D019288:Herpesvirus 8, Human / Q000235:genetics*; D006801:Humans; D016366:Open Reading Frames; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D012514:Sarcoma, Kaposi / Q000453:epidemiology* / Q000821:virology*
AIDS. 1997 Jul 15;11(9):1119-22
9233458
J Infect Dis. 1997 Jul;176(1):94-102
9207354
Br J Dermatol. 1997 Aug;137(2):179-84
9292063
J Med Virol. 1997 Sep;53(1):81-4
9298737
J Virol. 1997 Oct;71(10):8082-3
9311909
Arch Dermatol. 1997 Oct;133(10):1247-51
9382563
Blood. 1997 Dec 1;90(11):4278-82
9373238
Lancet. 1997 Dec 6;350(9092):1655-61
9400509
Science. 1997 Dec 12;278(5345):1972; author reply 1972-3
9417645
J Infect Dis. 1998 Jan;177(1):213-6
9419191
Am J Epidemiol. 1998 Feb 1;147(3):217-21
9482495
Lancet. 1998 Feb 28;351(9103):679-80
9500364
J Clin Invest. 1998 Apr 1;101(7):1500-8
9525993
Blood. 1998 Jun 1;91(11):4393-4
9596693
Blood. 1998 Oct 15;92(8):2681-7
9763550
Hum Pathol. 1998 Oct;29(10):1091-6
9781647
J Infect Dis. 1998 Nov;178(5):1546-7
9780286
J Infect Dis. 1998 Dec;178(6):1610-5
9815212
Blood. 1999 Feb 1;93(3):1110-1
10025982
Blood. 1999 Mar 1;93(5):1482-6
10029574
J Virol. 1999 May;73(5):4156-70
10196312
Blood. 1999 May 15;93(10):3157-9; discussion 3164-6
10233867
Blood. 1999 May 15;93(10):3159-63; discussion 3163-4
10233868
Semin Cancer Biol. 1999 Jun;9(3):187-99
10343070
J Virol. 1999 Aug;73(8):6646-60
10400762
J Leukoc Biol. 1999 Aug;66(2):357-60
10449181
J Infect Dis. 1999 Nov;180(5):1466-76
10515805
Am J Respir Crit Care Med. 2005 Dec 15;172(12):1581-5
16192453
Intervirology. 2006;49(3):133-43
16428889
Adv Dent Res. 2006;19(1):91-5
16672557
J Clin Microbiol. 2006 Jul;44(7):2409-15
16825357
Curr Top Microbiol Immunol. 2007;312:1-42
17089792
J Clin Virol. 2007 Sep;40(1):19-25
17690010
Rev Med Virol. 2002 Jan-Feb;12(1):47-63
11787083
Br J Haematol. 2000 Jan;108(1):197-8
10712004
J Infect Dis. 2000 May;181(5):1785-90
10823785
Nature. 2000 Sep 14;407(6801):151-2
11001045
Clin Cancer Res. 2000 Nov;6(11):4226-33
11106236
J Mol Diagn. 2001 Feb;3(1):32-8
11227070
Cancer. 2001 Apr 15;91(8):1409-13
11301386
J Clin Virol. 2002 Jan;23(3):119-48
11595592
J Gen Virol. 2002 Jul;83(Pt 7):1613-9
12075079
J Virol. 2003 Jun;77(11):6546-50
12743312
J Clin Microbiol. 2003 Jun;41(6):2492-7
12791871
J Infect Dis. 2003 Sep 1;188(5):678-89
12934184
N Engl J Med. 2003 Sep 18;349(12):1113-22
13679525
J Virol. 2004 Apr;78(8):4074-84
15047824
Oral Microbiol Immunol. 2004 Jun;19(3):201-4
15107073
Biotechniques. 1994 Feb;16(2):242-4, 246
8179886
Science. 1994 Dec 16;266(5192):1865-9
7997879
Lancet. 1995 Mar 25;345(8952):759-61
7891487
N Engl J Med. 1995 May 4;332(18):1181-5
7700310
N Engl J Med. 1995 May 4;332(18):1186-91
7700311
Blood. 1995 Aug 15;86(4):1276-80
7632932
Lancet. 1995 Sep 23;346(8978):799-802
7674745
N Engl J Med. 1996 May 2;334(18):1168-72
8602183
Blood. 1996 Jun 15;87(12):4937-43
8652805
J Clin Microbiol. 1996 Oct;34(10):2635-8
8880542
J Infect Dis. 1997 Mar;175(3):703-7
9041349
Blood. 1997 Mar 1;89(5):1686-9
9057651
J Virol. 1997 May;71(5):4138-44
9094697
Science. 1997 Jun 20;276(5320):1851-4
9188529
J Neurol. 1997 Jul;244(7):450-4
9266465